Historically, biologically active molecules were mostly derived from botanical extracts. Aspirin was the first synthetic molecule modified from biologically active molecules derived from the extract...
Join the Yale Ventures Startup Speaker Series on Tuesday, August 6, to hear from Mark Johnson, Senior Quantum Evangelist at Quantinuum. The event is open...
The CLA 2024 Outlook series provides key insights to help both business owners and individuals. In our third-quarter update, we’ll discuss our updated economic outlook,...
Scientifically Speaking is a virtual event series designed to highlight JAX's distinctive combination of research, education and resources and our role in empowering the biomedical...
In this workshop, Danielle Silva, Assistant Vice President at Capital Advisors Group, will give an overview of the nuts and bolts of fundraising and venture...
The Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in defining and...
Whether you are interested in professional development, networking, fundraising, diversity in the workplace, or STEM — we have a program for you! WIB Membership Committee...
Correctly determining the inventors to list in a patent application is both challenging and important for protecting the patent’s value. This is especially true for...
Made available to BioCT members through our partnership with CLA and RI Bio. Do you have accounting questions related to your business? Mike Ung, CPA...
Join us for our virtual R&D day featuring experts in the field of cough and itch. Featuring: Peter Dicpinigaitis, MD Professor of Medicine, Albert Einstein...
